AAAAAA

   
Results: 1-25 |
Results: 25
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones
Authors: Havrilesky, LJ McMahon, CP Lobenhofer, EK Whitaker, R Marks, JR Berchuck, A
Citation: Lj. Havrilesky et al., Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones, J SOC GYN I, 8(2), 2001, pp. 104-113
Mycobacterium bovis peritonitis mimicking ovarian cancer in a young woman
Authors: Stout, JE Woods, CW Alvarez, AA Berchuck, A Hamilton, CD
Citation: Je. Stout et al., Mycobacterium bovis peritonitis mimicking ovarian cancer in a young woman, CLIN INF D, 33(4), 2001, pp. E14-E16
Allele loss on chromosome 1p36 in epithelial ovarian cancers
Authors: Alvarez, AA Lambers, AR Lancaster, JM Maxwell, GL Ali, S Gumbs, C Berchuck, A Futreal, PA
Citation: Aa. Alvarez et al., Allele loss on chromosome 1p36 in epithelial ovarian cancers, GYNECOL ONC, 82(1), 2001, pp. 94-98
K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary
Authors: Alvarez, AA Moore, WF Robboy, SJ Bentley, RC Gumbs, C Futreal, PA Berchuck, A
Citation: Aa. Alvarez et al., K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary, GYNECOL ONC, 80(2), 2001, pp. 201-206
Favorable survival associated with microsatellite instability in endometrioid endometrial cancers
Authors: Maxwell, GL Risinger, JI Alvarez, AA Barrett, JC Berchuck, A
Citation: Gl. Maxwell et al., Favorable survival associated with microsatellite instability in endometrioid endometrial cancers, OBSTET GYN, 97(3), 2001, pp. 417-422
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markersfor epithelial ovarian carcinoma - A critical appraisal
Authors: van Haaften-Day, C Shen, Y Xu, FJ Yu, YH Berchuck, A Havrilesky, LJ de Bruijn, HWA van der Zee, AGJ Bast, RC Hacker, NF
Citation: C. Van Haaften-day et al., OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markersfor epithelial ovarian carcinoma - A critical appraisal, CANCER, 92(11), 2001, pp. 2837-2844
Mutational analysis of the PTEN gene in human uterine sarcomas
Authors: Lancaster, JM Risinger, JI Carney, ME Barrett, JC Berchuck, A
Citation: Jm. Lancaster et al., Mutational analysis of the PTEN gene in human uterine sarcomas, AM J OBST G, 184(6), 2001, pp. 1051-1053
Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers
Authors: Maxwell, GL Risinger, JI Hayes, KA Alvarez, AA Dodge, RK Barrett, JC Berchuck, A
Citation: Gl. Maxwell et al., Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers, CLIN CANC R, 6(8), 2000, pp. 2999-3005
Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: Amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma
Authors: Ahmed, MN Kim, K Haddad, B Berchuck, A Qumsiyeh, MB
Citation: Mn. Ahmed et al., Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: Amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma, CANC GENET, 116(1), 2000, pp. 10-15
Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovary
Authors: Moore, WF Bentley, RC Berchuck, A Robboy, SJ
Citation: Wf. Moore et al., Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovary, AM J SURG P, 24(5), 2000, pp. 710-718
Elevated serum CA-125 levels: Hepatitis or ascites? Reply
Authors: Berchuck, A Myers, E
Citation: A. Berchuck et E. Myers, Elevated serum CA-125 levels: Hepatitis or ascites? Reply, GYNECOL ONC, 76(1), 2000, pp. 142-143
Prognostic factors in early-onset epithelial ovarian cancer: A population-based study
Authors: Schildkraut, JM Halabi, S Bastos, E Marchbanks, PA McDonald, JA Berchuck, A
Citation: Jm. Schildkraut et al., Prognostic factors in early-onset epithelial ovarian cancer: A population-based study, OBSTET GYN, 95(1), 2000, pp. 119-127
ARHI is the center of allelic deletion on chromosome 1p31 ovarian and breast cancers
Authors: Peng, HQ Xu, FJ Pershad, R Hunt, KK Frazier, ML Berchuck, A Gray, JW Hogg, D Bast, RC Yu, YH
Citation: Hq. Peng et al., ARHI is the center of allelic deletion on chromosome 1p31 ovarian and breast cancers, INT J CANC, 86(5), 2000, pp. 690-694
An approach to analysis of large-scale correlations between genome changesand clinical endpoints in ovarian cancer
Authors: Suzuki, S Moore, DH Ginzinger, DG Godfrey, TE Barclay, J Powell, B Pinkel, D Zaloudek, C Lu, K Mills, G Berchuck, A Gray, JW
Citation: S. Suzuki et al., An approach to analysis of large-scale correlations between genome changesand clinical endpoints in ovarian cancer, CANCER RES, 60(19), 2000, pp. 5382-5385
Genetic susceptibility testing and prophylactic oophorectomy
Authors: Berchuck, A Carney, ME Futreal, PA
Citation: A. Berchuck et al., Genetic susceptibility testing and prophylactic oophorectomy, EUR J OB GY, 82(2), 1999, pp. 159-164
Cost-effectiveness of treatment of early stage endometrial cancer
Authors: Ashih, H Gustilo-Ashby, T Myers, ER Andrews, J Clarke-Pearson, DL Berry, D Berchuck, A
Citation: H. Ashih et al., Cost-effectiveness of treatment of early stage endometrial cancer, GYNECOL ONC, 74(2), 1999, pp. 208-216
Allelic loss on chromosome arm 8p: Analysis of sporadic epithelial ovariantumors
Authors: Brown, MR Chuaqui, R Vocke, CD Berchuck, A Middleton, LP Emmert-Buck, MR Kohn, EC
Citation: Mr. Brown et al., Allelic loss on chromosome arm 8p: Analysis of sporadic epithelial ovariantumors, GYNECOL ONC, 74(1), 1999, pp. 98-102
Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses
Authors: Zhang, Z Barnhill, SD Zhang, H Xu, FJ Yu, YH Jacobs, I Woolas, RP Berchuck, A Madyastha, KR Bast, RC
Citation: Z. Zhang et al., Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses, GYNECOL ONC, 73(1), 1999, pp. 56-61
Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations
Authors: Zweemer, RP Shaw, PA Verheijen, RMH Ryan, A Berchuck, A Ponder, BAJ Risch, H McLaughlin, JR Narod, SA Menko, FH Kenemans, P Jacobs, IJ
Citation: Rp. Zweemer et al., Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations, J CLIN PATH, 52(5), 1999, pp. 372-375
Managing hereditary ovarian cancer risk
Authors: Berchuck, A Schildkraut, JM Marks, JR Futreal, PA
Citation: A. Berchuck et al., Managing hereditary ovarian cancer risk, CANCER, 86(8), 1999, pp. 1697-1704
Managing hereditary ovarian cancer risk
Authors: Berchuck, A Schildkraut, JM Marks, JR Futreal, PA
Citation: A. Berchuck et al., Managing hereditary ovarian cancer risk, CANCER, 86(11), 1999, pp. 2517-2524
Bcl10 is not a target for frequent mutation in human carcinomas
Authors: Lambers, AR Gumbs, C Ali, S Marks, JR Iglehart, JD Berchuck, A Futreal, PA
Citation: Ar. Lambers et al., Bcl10 is not a target for frequent mutation in human carcinomas, BR J CANC, 80(10), 1999, pp. 1575-1576
PTEN mutation in endometrial cancers is associated with favorable clinicaland pathologic characteristics
Authors: Risinger, JI Hayes, K Maxwell, GL Carney, ME Dodge, RK Barrett, JC Berchuck, A
Citation: Ji. Risinger et al., PTEN mutation in endometrial cancers is associated with favorable clinicaland pathologic characteristics, CLIN CANC R, 4(12), 1998, pp. 3005-3010
Mutations in the PTEN tumor suppressor gene in cervical carcinomas
Authors: Maxwell, GL Risinger, JI Shaw, H Alvarez, A Barrett, JC Futreal, PA Berchuck, A
Citation: Gl. Maxwell et al., Mutations in the PTEN tumor suppressor gene in cervical carcinomas, INT J GYN C, 8(6), 1998, pp. 489-493
Allelotype analysis of uterine leiomyoma: Localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q
Authors: van der Heijden, O Chiu, HC Park, TC Takahashi, H LiVolsi, VA Risinger, JI Barrett, JC Berchuck, A Evans, AC Behbakht, K Menzin, AW Liu, PC Benjamin, I Morgan, MA King, SA Rubin, SC Boyd, J
Citation: O. Van Der Heijden et al., Allelotype analysis of uterine leiomyoma: Localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q, MOL CARCINO, 23(4), 1998, pp. 243-247
Risultati: 1-25 |